Browse > Article
http://dx.doi.org/10.3345/cep.2020.01228

Inhibition of the renin-angiotensin system during fetal kidney development  

Park, Eujin (Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.64, no.3, 2021 , pp. 121-122 More about this Journal
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Verdecchia P, Angeli F, Mazzotta G, Gentile G, Reboldi G. The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc Health Risk Manag 2008;4:971-81.   DOI
2 Gomez RA, Norwood VF. Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 1995;26:409-31.   DOI
3 Gubler MC, Antignac C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int 2010;77:400-6.   DOI
4 Uematsu M, Sakamoto O, Nishio T, Ohura T, Matsuda T, Inagaki T, et al. A case surviving for over a year of renal tubular dysgenesis with compound heterozygous angiotensinogen gene mutations. Am J Med Genet A 2006;140:2355-60.
5 Gang MH, Lee YW, Chang M. Secondary renal tubular dysgenesis in a newborn exposed to angiotensin II receptor antagonist during fetal life. Clin Exp Pediatr 2020 Jul 21 [Epub]. https://doi.org/10.3345/cep.2020.00752.   DOI
6 Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13-115.   DOI
7 Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004;116:263-72.   DOI
8 Hinchliffe SA, Sargent PH, Howard CV, Chan YF, van Velzen D. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle. Lab Invest 1991;64:777-84.
9 Duminy PC, Burger PD. Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J 1981;60:805.
10 Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 2012;60:444-50.   DOI